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It is just over a year since the European Journal of rehabilitation and radiological interventions. For more
information on areas requiring review, please contactVascular and Endovascular Surgery began publishing
abstracts of reviews written within the Cochrane Re- Dr Elizabeth Royle, the Review Group Co-ordinator.
view Group on Peripheral Vascular Diseases (PVD).
This important initiative has ensured increased ex-
posure of important conclusions and research re-
Help in conducting a reviewcommendations. Full versions of these reviews are
available on the Cochrane Library, published quarterly
Prior experience of conducting a systematic review ison CD ROM and the Internet by Update Software
a useful, but not an essential, requirement for pre-(Oxford, U.K.). Unlike reviews published in traditional
paring a Cochrane review. The PVD Group will ensurejournals, Cochrane reviews are continually updated;
that you receive as much or as little training andtherefore, whenever new trial evidence becomes avail-
support as you require. This includes providing writ-able, it is incorporated into the existing review. Any
ten guidelines, help with choosing relevant outcomeupdated reviews, where there have been significant
measures, providing workshops, training courses andchanges to the conclusions as a result of the inclusion
ad hoc help by telephone or e-mail. The Group canof new evidence, will also appear in the European
also fund U.K. travel expenses for authors who wouldJournal of Vascular and Endovascular Surgery.
like to spend time preparing their review at the Ed-
itorial Base in Edinburgh, where assistance is readily
available. The Group is also aware that busy clinicians
Need for More Reviews often struggle to find sufficient time to undertake a
systematic review, and is therefore aiming to facilitate
The ultimate aim of the Cochrane PVD Group is to this process through a variety of strategies, including
produce systematic reviews of all available evidence the possibility of obtaining approval from the Com-
in areas relevant to PVD. This covers most aspects of mittee of Medical Education for attendance at Group
the prevention and treatment of peripheral vascular meetings and workshops, and also for preparing and
disease, including abdominal aortic aneurysm, peri- maintaining reviews.
pheral aneurysm, atherosclerosis, critical limb isch-
aemia, vasospasm, thromboembolism, varicose veins
and chronic venous insufficiency. Reviews are cur-
rently under way in many of these areas, but more Need for More Trials
are still required, particularly in relation to amputation
resulting from peripheral vascular disease, vasospasm, In addition to more systematic reviews, there is also
a fundamental requirement for more primary research
evidence. Although there are nearly 3000 trials on the
* Editor, Cochrane Review Group on Peripheral Vascular Diseases. PVD Group’s database, many of these studies are small† Review Group Co-ordinator, Cochrane Review Group on
Peripheral Vascular Diseases. and of poor quality. As a result, many reviews conclude
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by highlighting the lack of evidence currently avail- claudication and following bypass grafting to
determine the effect on walking distance andable. It is important, therefore, that these unanswered
mortality.questions are addressed, in multicentre trials if neces-
• A three-arm trial comparing vitamin E to anothersary. Areas that have been identified by recent
treatment as well as placebo, in patients with clau-Cochrane PVD Group reviews as requiring further
dication, with the evaluation including need forresearch are listed below:
amputation and vascular surgery.
• Trials of exercise to determine the most effective way• Angioplasty trials of sufficient size to take into
of providing therapy and to establish the duration ofaccount clinical heterogeneity in, for example, the benefit.
site of the lesion.
• Statin therapy in patients with intermittent Accepted 5 July 1999
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